Publication: Comparison of methotrexate and Azathioprine as the first steroid-sparing immunosuppressive agent in patients with Takayasu's Arteritis
Program
KU-Authors
Kanıtez, Nilüfer Alpay
KU Authors
Co-Authors
Kaymaz-Tahra, Sema
Tsechelidis, Ozun Bayindir
Ince, Burak
Isik, Ozlem Ozdemir
Kutu, Muhammet Emin
Karakas, Ozlem
Yildirim, Tuba Demirci
Ademoglu, Zeliha
Ediboglu, Elif Durak
Uludogan, Burcu Ceren Ekti
Advisor
Publication Date
Language
Type
Journal Title
Journal ISSN
Volume Title
Abstract
Background
Conventional disease-modifying anti-rheumatic drugs (cDMARDs) are recommended in addition to glucocorticoids (GC) for all active Takayasu's arteritis (TAK) patients as the first-line therapy.However, there is limited data comparing cDMARDs as the first-line immunosuppressive (IS) treatment.
Objectives
In this study, we aimed to compare the outcomes of methotrexate (MTX) and azathioprine (AZA), which were used most frequently as the first-line cDMARDs in TAK patients.
Source:
ARTHRITIS and RHEUMATOLOGY
Publisher:
Wiley
Keywords:
Subject
Rheumatology